Financhill
Back

Monopar Therapeutics, Inc. Stock Price Chart

  • The current trend is relatively stagnant and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

Monopar Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 82.26 Sell
20-day SMA: 83.02 Sell
50-day SMA: 85.12 Sell
200-day SMA: 50.31 Buy
8-day EMA: 81.31 Sell
20-day EMA: 82.57 Sell
50-day EMA: 78.83 Buy
200-day EMA: 54.97 Buy

Monopar Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 47.21 Sell
Chaikin Money Flow: -71961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.86 - 87.26) Sell
Bollinger Bands (100): (41.98 - 87.26) Buy

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Monopar Therapeutics, Inc. Stock

Is Monopar Therapeutics, Inc. Stock a Buy?

MNPR Technical Analysis vs Fundamental Analysis

Sell
48
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy or a Sell?

Monopar Therapeutics, Inc. Stock Info

Market Cap:
537.1M
Price in USD:
80.38
Share Volume:
105.7K

Monopar Therapeutics, Inc. 52-Week Range

52-Week High:
105.00
52-Week Low:
20.61
Sell
48
Monopar Therapeutics, Inc. (MNPR) is a Sell

Monopar Therapeutics, Inc. Share Price Forecast

Is Monopar Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Monopar Therapeutics, Inc.

Is Monopar Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Technical Analysis of Monopar Therapeutics, Inc.

Should I short Monopar Therapeutics, Inc. stock?

* Monopar Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.